Total Payments
$2,318
2024 Payments
$438.14
Companies
23
Transactions
52
Medicare Patients
2,548
Medicare Billing
$286,038
Payment Breakdown by Category
Food & Beverage$2,318 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,318 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $777.16 | 15 | $0 (2024) |
| SI-BONE, INC. | $282.38 | 2 | $0 (2024) |
| Seapearl East, Inc | $126.27 | 1 | $0 (2024) |
| Amarin Pharma Inc. | $124.97 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $120.65 | 1 | $0 (2017) |
| ABBVIE INC. | $120.17 | 6 | $0 (2024) |
| Boston Scientific Corporation | $119.42 | 2 | $0 (2019) |
| Abbott Laboratories | $83.39 | 2 | $0 (2020) |
| PFIZER INC. | $72.57 | 5 | $0 (2020) |
| Medtronic USA, Inc. | $71.34 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $438.14 | 9 | SI-BONE, INC. ($151.95) |
| 2023 | $256.81 | 7 | SI-BONE, INC. ($130.43) |
| 2022 | $185.29 | 4 | Nevro Corp. ($140.98) |
| 2021 | $101.44 | 3 | Orthofix Medical, Inc. ($61.33) |
| 2020 | $160.86 | 6 | Nevro Corp. ($130.81) |
| 2019 | $389.82 | 13 | Amarin Pharma Inc. ($124.97) |
| 2018 | $283.49 | 4 | Nevro Corp. ($247.22) |
| 2017 | $501.78 | 6 | Nevro Corp. ($143.46) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Seapearl East, Inc | — | Food and Beverage | In-kind items and services | $126.27 | General |
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/20/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/01/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $151.95 | General |
| 06/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/19/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $34.72 | General |
| Category: NEUROLOGY | ||||||
| 01/26/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/08/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $130.43 | General |
| 08/23/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: Pain Management | ||||||
| 06/30/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/09/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/02/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/22/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/04/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $140.98 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/29/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/18/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: HYPERHYDROSIS | ||||||
| 01/14/2022 | DePuy Synthes Sales Inc. | MONOVISC (Device) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Sports Early Intervention | ||||||
| 11/01/2021 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: PENNSAID | ||||||
| 08/02/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/03/2021 | Orthofix Medical, Inc. | Cervical-STIM (Device) | Food and Beverage | In-kind items and services | $61.33 | General |
| Category: Stimulator, Bone Growth, Non-Invasive | ||||||
| 09/01/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/29/2020 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $14.86 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 341 | 889 | $95,069 | $35,242 |
| 2022 | 20 | 594 | 2,027 | $190,044 | $55,233 |
| 2021 | 22 | 789 | 4,794 | $303,337 | $105,136 |
| 2020 | 28 | 824 | 3,766 | $240,124 | $90,428 |
Total Patients
2,548
Total Services
11,476
Medicare Billing
$286,038
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 82 | $16,400 | $8,780 | 53.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 101 | $15,200 | $7,476 | 49.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 16 | 17 | $8,483 | $3,989 | 47.0% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 11 | 12 | $21,999 | $2,973 | 13.5% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 41 | 66 | $6,536 | $2,972 | 45.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 11 | 23 | $4,600 | $1,995 | 43.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,600 | $1,767 | 49.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,600 | $1,590 | 44.2% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 21 | 30 | $7,260 | $1,559 | 21.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 55 | 101 | $2,201 | $1,195 | 54.3% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 11 | 14 | $2,786 | $781.06 | 28.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 53 | 413 | $2,405 | $164.21 | 6.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 127 | $19,050 | $9,404 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 77 | $15,325 | $7,838 | 51.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 22 | 24 | $72,000 | $6,309 | 8.8% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 18 | 19 | $9,481 | $4,699 | 49.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 22 | 47 | $9,400 | $4,323 | 46.0% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 38 | 79 | $7,823 | $3,958 | 50.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $6,000 | $2,907 | 48.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 57 | 59 | $8,850 | $2,881 | 32.6% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 25 | 54 | $13,067 | $2,838 | 21.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 61 | 135 | $2,882 | $1,684 | 58.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,300 | $1,675 | 50.8% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 14 | 16 | $3,200 | $1,506 | 47.1% |
| 97530 | Therapy procedure using functional activities | Office | 2022 | 18 | 48 | $2,400 | $1,446 | 60.3% |
About Dr. Binod Shah, MD
Dr. Binod Shah, MD is a Physical Medicine & Rehabilitation healthcare provider based in Yonkers, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346334604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Binod Shah, MD has received a total of $2,318 in payments from pharmaceutical and medical device companies, with $438.14 received in 2024. These payments were reported across 52 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,318).
As a Medicare-enrolled provider, Shah has provided services to 2,548 Medicare beneficiaries, totaling 11,476 services with total Medicare billing of $286,038. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Yonkers, NY
- Active Since 10/03/2006
- Last Updated 05/31/2013
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1346334604
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $543.31
- Omnia (Device) $154.56
- BOTOX (Biological) $127.59
- Vascepa (Drug) $124.97
- XARELTO (Drug) $120.65
- 32 CONTACT (Device) $100.26
- Senza (Device) $79.29
- ADAPTIVESTIM (Device) $71.34
- Proclaim Family of SCS IPGs (Device) $68.20
- OVERSTITCH (Device) $66.07
- Cervical-STIM (Device) $61.33
- LYRICA (Drug) $57.71
- Durolane (Device) $37.46
- VYEPTI (Biological) $34.72
- Iovera (Device) $30.36
- SEGLENTIS (Drug) $27.26
- PENNSAID (Drug) $26.53
- QUTENZA (Drug) $26.05
- Catheters and Needles (Device) $22.94
- Epidural needles and catheters (Device) $22.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.